Unveiling risk factors: a prognostic model of frequent peritonitis in peritoneal dialysis patients

Qi-Jiang Xu1,2, Zhi-Yun Zang1, Xue-Li Zhou1,3

  • 1Department of Nephrology, Institute of Nephrology, West China Hospital of Sichuan University, Chengdu, China.

Frontiers in Medicine
|February 13, 2025
PubMed

Insights

This study developed a risk prediction model to identify patients with frequent peritoneal dialysis-associated peritonitis (PDAP) episodes. The model, using factors like diabetes and albumin, showed excellent predictive performance.

Area of Science:

  • Nephrology
  • Internal Medicine
  • Clinical Epidemiology

Background:

  • Peritoneal dialysis-associated peritonitis (PDAP) is a significant complication for patients undergoing peritoneal dialysis (PD).
  • Identifying patients at high risk for frequent PDAP episodes is crucial for improving patient outcomes and management strategies.

Purpose of the Study:

  • To construct and validate a risk prediction model for frequent PDAP episodes in PD patients.
  • To develop a user-friendly tool, such as a nomogram, for assessing individual patient risk.

Main Methods:

  • A retrospective cohort study of 371 PDAP patients from January 2010 to December 2021.
  • Binary logistic regression was employed to build the risk prediction model.
  • Patients were randomly allocated into training (80%) and test (20%) sets for model development and validation.

Main Results:

  • The final model identified key risk factors for frequent PDAP: diabetes mellitus (DM), hemoglobin (HB), serum albumin (ALB), lactate dehydrogenase (LDH), serum potassium (K), N-terminal pro-brain natriuretic peptide (NT-proBNP), and peritoneal dialysate white cell count on day 1.
  • The model achieved an area under the curve (AUC) of 0.75 in the training set and 0.76 in the test set, indicating excellent predictive accuracy.
  • A nomogram was developed for intuitive risk assessment.

Conclusions:

  • The developed predictive model demonstrates strong performance in identifying PDAP patients at high risk for frequent episodes.
  • The nomogram provides a practical tool for clinicians to evaluate patient risk.
  • Further validation through larger, multicenter studies is recommended to confirm the model's generalizability.
Abstract